Fibrotech Therapeutics
Latest round
- Series A
Last raised
- Feb 2009
Total raised
- $2M
Investors
- 2
About Fibrotech Therapeutics
Based in Australia, founded in 2006, Fibrotech Therapeutics is a drug development company. It is developing orally active anti-fibrotic inhibitors to treat an unmet clinical need.
Who invested in Fibrotech Therapeutics
2 investors across 1 round
See all investors in Fibrotech Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 10, 2009
Amount
$2M
Investors
Questions about Fibrotech Therapeutics
Who invested in Fibrotech Therapeutics?
Fibrotech Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Fibrotech Therapeutics raised?
Fibrotech Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Fibrotech Therapeutics last raise money?
Fibrotech Therapeutics's most recent round on record is a Series A, in Feb 2009.
What does Fibrotech Therapeutics do?
Based in Australia, founded in 2006, Fibrotech Therapeutics is a drug development company.
Where is Fibrotech Therapeutics headquartered?
Fibrotech Therapeutics is headquartered in Melbourne, Australia.
Which VCs invest in companies like Fibrotech Therapeutics?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back pharmaceuticals companies at Fibrotech Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Fibrotech Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.